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Short Title: Biomimetic surface functionalization of metals. 
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Abstract  
Titanium and its alloys or tantalum (Ta) are materials used in orthopaedic and dental implants due to their 
excellent mechanical properties and biocompatibility. However, their bioactivity and osteoconductivity is low.  
With a view to improving these materials bioactivity we hypothesised that the surface of Ta and TiAl6V4 can be 
functionalised with biomimetic, amorphous nano-sized calcium-phosphate (CaP) apatite-like deposits, instead of 
creating uniform coatings, which can lead to flaking, delamination and poor adherence. We used Ta and 
TiAl6V4 metal discs with smooth and rough surfaces. Amorphous CaP apatite-like particles were deposited on 
the different surfaces by a biomimetic rapid two-step soaking method using concentrated simulated body fluid 
(SBF) solutions without a pre-treatment of the metal surfaces to induce CaP deposition. Immersion times in the 
second SBF solution of 48 h and 18 h for Ta and TiAl6V4 respectively produced CaP deposits composed of 
amorphous globular nano-sized particles that also contained Mg, C and O. Longer immersion times produced 
more uniform coatings as well as an undesired calcite mineral phase. Prediction of in vivo behaviour by 
immersion in regular SBF showed that the obtained CaP deposits would act as a catalyst to rapidly form a Ca 
deficient CaP layer that also incorporates Mg. The amorphous CaP apatite-like deposits promoted initial 
attachment, proliferation and osteogenic differentiation of bone marrow derived mesenchymal stem cells. 
Finally, we used our method to functionalise 3D porous structures of titanium alloy made by selective laser 
sintering. Our study uses a novel and cost-effective approach to functionalise clinically relevant metal surfaces 
in order to increase the bioactivity of these materials, which could improve their clinical performance.  
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1. Introduction 
Metals such as titanium (Ti) and its alloys or tantalum (Ta) are materials used in orthopaedic and dental 
implants due to their excellent mechanical properties and biocompatibility [1-4]. However, they present certain 
disadvantages with low bioactivity and poor osteoconductivity being notable ones [5]. Therefore, a significant 
amount of research is carried out to confer increased bioactivity to these materials. As surface properties of 
metal implants are critical features for rapid and stable integration with bone tissue the vast majority of this 
research focuses on surface modification and functionalization [5-7].  
 
Surface topography modification has been extensively explored with studies showing that increasing surface 
roughness increases bone formation (osteoconduction) on the implant surface [8]. It has been shown both in 
vitro and in vivo that rough Ti surfaces promote osteogenic cell differentiation [8,9]. Moreover, a recent in vitro 
study by Hotchkiss and colleagues demonstrated the effect of Ti surface topography and wettability on 
macrophage activation and cytokine production [10]. Their results showed that macrophages cultured on rough, 
wettable metal surfaces produce an anti-inflammatory environment that may improve the healing response to 
implanted metal materials [10]. 
 
Another significant area of research is metal surface functionalization through deposition of a coating layer, 
commonly calcium phosphate (CaP) coatings due to their chemical similarity with bone mineral [1]. Apart from 
their excellent bioactivity, CaP materials and coatings are osteoconductive as they form a direct bond with bone 
tissue through formation of an apatite layer when implanted in vivo [11]. Another reason for the good 
osteointegration shown by CaP materials in vivo is that natural cytokines and adhesive proteins such as 
fibronectin adsorb to the surface of these materials providing a matrix for cell attachment [12,13]. However, the 
application of CaP coatings is limited by their relatively poor mechanical properties leading to flaking and 
delamination [14,15]. Another potential limitation of CaP coatings and materials is their composition. 
According to the current state of knowledge, bone mineral was recently described by Habraken and co-workers 
as “a poorly crystalline, highly substituted apatite consisting of very small crystals” [16]. The crystals in bone 
mineral are nanometer-sized platelets or needles that contain several ionic substitutions such as Mg2+,  Na+ and 
Sr2+ in Ca2+ sites or CO3
2- in OH- (A-substitution) and PO4
3- sites (B-substitution). In contrast, current CaP 
phases used for coatings i.e. hydroxyapatite [Ca10(PO4)6(OH)2 with Ca/P=1.67] or β-tricalcium phosphate [β-
Ca3(PO4)2 with Ca/P=1.50] lack the chemical variability of bone mineral. A current research trend is to produce 
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CaP materials that consist of precursor phases i.e. amorphous calcium phosphate [Ca3(PO4)2·zH2O where z = 3–
4.5 in basic conditions and M3(Ca3(HPO4)4.5·zH2O) where z is unknown and M is typically a monovalent cation 
(Na+, K+, NH4
+) in acidic conditions; Ca/P=0.67-1.50] or octacalcium phosphate [Ca8H2(PO4)6·5H2O with 
Ca/P=1.33] that can be rapidly converted to apatite after implantation [16]. 
 
For this study, we hypothesised that the surface of clinically relevant metals used in dental and orthopaedic 
implants can be functionalised with biomimetic, amorphous CaP apatite-like deposits. Our aim was to 
functionalise the metal surfaces with CaP deposits rather than creating uniform coatings, which can lead to 
flaking and delamination due to their relatively poor mechanical properties. Another aim of our work was to 
obtain CaP deposits composed of nano-particles, as the crystals in bone mineral are nano-sized. As both metals 
are widely used in dental and orthopaedic applications we used TiAl6V4 alloy and pure Ta metals, both with 
smooth and rough surfaces. Amorphous CaP apatite-like mineral particles were deposited on the different 
surfaces by a biomimetic soaking method using simulated body fluid (SBF) solutions without a pre-treatment of 
the metal surfaces to induce CaP deposition, thus offering an advantage in terms of simplicity and cost-
effectiveness. As this method is not a line of sight coating then it can be used for treating the internal surfaces of 
porous alloys made by selective laser sintering. Prediction of in vivo behaviour was carried out by immersion in 
regular SBF. Finally, in vitro cell work using a clinically relevant source of cells (bone marrow derived 
mesenchymal stem cells, BM MSCs) was conducted to examine the biocompatibility and the osteogenic 
potential of the amorphous CaP deposits. Our study uses a novel and cost-effective approach to functionalise 
clinically relevant metal surfaces in order to increase the bioactivity of these materials, which could improve 
their clinical performance. 
 
 
2. Materials and Methods 
2.1 Materials 
10 mm diameter × 2 mm thickness discs of pure Tantalum (Ta) and TiAl6V4 were used in this study (Fig. 1). 
Discs’ surfaces were polished using silicon carbide grinding papers (Buehler, Germany) in a grinding machine 
(EXACT, Germany). Half of the discs were sandblasted using alumina particles (Al2O3) to obtain an average 
roughness of Ra=4.0 µm (Plasma Biotal Limited, UK). Samples were ultrasonically cleaned in acetone, 70% 
ethanol and distilled water for 15 minutes and air dried prior to the biomimetic soaking method. TiAl6V4 cubes 
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with 70% porosity were approximately 10 mm length, width and thickness (Eurocoating S.p.a, Ciré-Pergine, 
Italy), with 700-850 µm voids and 350-480 µm struts, fabricated using selective laser sintering (Fig. 1). 
 
 
Figure 1. Materials used in this study. A) Ta discs after being polished showing a smooth surface; B) sand-
blasted Ta discs showing a rough surface; C) TiAl6V4 discs before being polished to obtain a smooth surface; 
D) sand-blasted TiAl6V4 discs showing a rough surface. Polished or rough Ta and TiAl6V4 discs had identical 
macroscopic appearance. E) Macroscopic image of porous TiAl6V4 cubes; F) microscopic view of the porous 
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TiAl6V4 material as supplied by the manufacturer; G and H) SEM images of the porous TiAl6V4 material 
revealing a rough surface. 
 
 
2.2 Biomimetic soaking method 
Table 1 shows the ion composition and concentration (mM) for both soaking solutions SBF-1 and SBF-2 as 
well as for regular SBF and human blood plasma (HBP). The appropriate quantities of reagent grade salts 
(NaCl, NaHCO3, Na2HPO4, MgCl2·6H2O and CaCl2·2H2O; all BDH, UK) were dissolved in distilled water at 
37ºC with a constant 5% CO2 supply and stirring. Discs were firstly soaked in SBF-1, a solution 5 times more 
concentrated than regular SBF, for 24 h at 37ºC with constant vigorous stirring. Discs were soaked in SBF-2 
solution, which has decreased concentrations of crystal growth inhibitors (Mg2+ and HCO3
-), at 50ºC with 
constant stirring. In order to obtain amorphous CaP apatite-like crystals soaking time in SBF-2 was optimised 
first in Ta discs, which were soaked in SBF-2 for 48 h, 60 h or 72 h. Based on the results obtained for Ta discs, 
TiAl6V4 were soaked in SBF-2 for 18 h, 24 h or 48 h. Discs were not washed between the two soaking steps. 
Both steps were carried out in an incubator with 5% CO2. The first step was carried out at 37ºC.  For the second 
soaking step, the temperature was raised to 50ºC using a hot plate controlled with a thermometer. Finally, discs 
were cleaned in distilled water and air-dried for further analysis (Fig. 2).  
 
 
 
Ion Concentration (mM) 
Solution Na
+
 K
+
 Ca
2+
 Mg
2+
 Cl
-
 HPO4
2-
 HCO3
-
 SO4
2-
 
HBP 142.0 5.0 2.5 1.5 103.0 1.0 27.0 0.5 
SBF 142.0 5.0 2.5 1.5 148.8 1.0 4.2 - 
SBF-1 714.8 - 12.5 7.5 723.8 5.0 21.0 - 
SBF-2 704.2 - 12.5 1.5 711.8 5.0 10.5 - 
Table 1: Composition and concentration of ions present in human blood plasma (HBP), regular simulated body  
fluid (SBF) and soaking solutions SBF-1 and SBF-2. 
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Figure 2. Diagram summarising the biomimetic soaking method used in this study.  
 
 
2.3 Scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EDAX) 
Morphology and size of mineral deposits were observed by SEM. Specimens were mounted on stubs and 
gold/palladium sputtered coated before observation under SEM (JEOL JSM 5500 LV). Elemental analysis was 
carried out by EDAX (EDAX Inc. USA). Calcium to Phosphorous (Ca/P) ratio was calculated from the 
quantitative data of the spectra (Atomic % Ca Kα / Atomic % P Kα). 
 
2.4 X-ray diffraction (XRD) 
Phase composition and crystallinity of the CaP deposits were studied by XRD using a Brüker D8 Advance 
Diffractometer (Brüker, UK) operated with Ni-filtered Cu Kα radiation and Brüker Lynx Eye detector. Data 
was collected from 2θ = 10º to 100º with a step size of 0.02º and a count time of 12 s per point. 
 
2.5 Micro-Raman spectroscopy 
Micro-Raman dispersion measurements were performed using a DILOR XY spectrometer with a CCD detector 
and a spectral resolution of 1.4 cm-1. The 514.53 nm line of an Ar+ ion laser was used as the excitation source 
and the scattered light was collected either through an X50 or X100 microscope objective lens.  
 
2.6 Thickness of CaP deposits 
Discs and porous 3D cubes were embedded in hard grade acrylic resin (LR White Resin, Agar Scientific), 
transversely cut using EXACT diamond band saw (EXACT, Germany) and polished using silicon carbide 
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grinding papers (Buehler, Germany) in a grinding machine (EXACT, Germany). Transversal sections were 
analysed by SEM. 
 
2.7 Apatite layer formation 
SBF (Table 1) was prepared using the appropriate quantities of reagent grade salts (NaCl, KCl, NaHCO3, 
K2HPO4, MgCl2·6H2O and CaCl2·2H2O; all BDH, UK) dissolved in distilled water with constant stirring. The 
solution was buffered at pH 7.25 with (CH2OH)3CNH2 50mM/HCl 45mM buffer and kept at 37ºC. Discs were 
immersed for up to 7 days in SBF at 37ºC and surfaces analysed by SEM and EDAX at days 0, 1 and 7.  
 
2.8 Culture and characterisation of ovine BM-MSCs 
BM-MSCs were isolated from sheep bone marrow aspirates using Ficoll® gradients, expanded and maintained 
in tissue culture flasks. Dulbecco’s modified eagles medium (Sigma-Aldrich, UK) with 10% fetal calf serum 
(First Link, UK) and 100 Units/mL of Penicillin/Streptomycin (Gibco, UK) (DMEM+) was used. Flasks were 
kept at 37ºC / 5%CO2 and passaged when 80% confluent. BM-MSCs were differentiated down the adipogenic 
and osteogenic lineages to demonstrate their multipotency. For the adipogenic differentiation, 1×105 cells at P5 
were seeded and cultured under either adipogenic (DMEM+ with 1µM dexamethasone, 200µM indomethacin, 
500µM 1-methyl-3-isobutylxanthine and 10µg/mL Insulin; all from Sigma-Aldrich, UK) or standard conditions 
for 21 days on Thermanox™ discs placed at the bottom of the wells of a 12 well plate (Nalge Nunc 
International, USA). Media were changed every 3-5 days. After 21 days, presence of lipids was checked by Oil 
Red O staining. For the osteogenic differentiation, 3×104 cells at P5 were seeded and cultured under either 
osteogenic (DMEM+ with 0.1µM dexamethasone, 500µM ascorbic acid and 10mM β-glycerophosphate; all 
from Sigma-Aldrich, UK) or standard conditions up to 28 days on Thermanox™ discs. Media were changed 
every 3-5 days. Cell proliferation (DNA assay) and alkaline phosphatase (ALP) production per µg of DNA were 
analysed at days 7, 14, 21 and 28. Changes in cellular morphology were observed by phase-contrast light 
microscopy and SEM while mineral deposition  was  determined  using Von Kossa staining at day 28.  
 
2.9 Culture of BM-MSCs on metal discs  
Discs were sterilised by autoclaving and seeded with BM-MSCs at P4 or P5. Each disc was seeded with 2.5x104 
cells (2x104 for SEM) in a total volume of 50µL of DMEM+ onto the centre of the disc. After incubation for 
100 minutes at 37ºC with 5%CO2, 2-3mL of DMEM+ was added to each well. 12-well plates were kept in a 
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37ºC with 5%CO2 incubator and media changed every 3-5 days. No osteogenic supplements were used. At days 
4, 7 and 14 of culture, cell attachment (SEM), cell proliferation (alamarBlue® and DNA assays) and early 
osteogenic differentiation (ALP production per µg of DNA and cell morphology by SEM) were studied. 
 
2.10 ALP activity and DNA assays 
Cells were washed in phosphate buffer saline (PBS) and lysed by adding sterile distilled water at 37ºC. After 
being frozen at -70ºC and thawed 3 times, samples were spun at 10,000 rpm for 10 minutes. 50 µL of the 
supernatant were loaded into Cobas Bio® blue sample cups (AS Diagnostics, UK). Pre-weighed p-nitrophenol 
phosphate powder was mixed with 10mL of diethanolamine buffer (both Randox, UK) and pre-heated to 37 ºC 
to produce the working solution, which was loaded along with the samples into the Cobas Bio® analyser 
(Roche, UK). 250 µL of working solution were used for each sample. The ALP activity was calculated as U/L 
and normalised for the number of cells in the samples. 100 µL of the same supernatant used for the ALP 
production assay were loaded in triplicate for each sample into a FluoroNuncTM white 96-well plate. 100 µL of 
DNA (Sigma-Aldrich, UK) standards, ranging from 20 to 0.3125µg/mL, were loaded in triplicate. 100 µL of 1.0 
µg/mL Hoechst 33258 dye (Sigma-Aldrich, UK) were added to each sample and fluorescence was read at 460 
nm using a plate reader (Fluoroskan Ascent, Labsystems, USA). The amount of DNA in the samples was 
calculated as µg of DNA. ALP/DNA was expressed as U/µg. 
 
2.11 alamarBlue® assay 
3mL of 10% alamarBlue® (AbD Serotec, UK) diluted in phenol free DMEM (Sigma, UK) was added to the 
samples and an empty well (reference) and incubated at 37ºC with 5%CO2 for 4 h. 100 µL from each sample 
was loaded in triplicate into a FluoroNuncTM white 96-well plate and fluorescence emission measured at 590 nm 
(Fluoroskan Ascent, Labsystems, USA).  
 
2.12 Von Kossa staining 
Cells were fixed in methanol, covered with 1.5% silver nitrate (Sigma, UK) and exposed to bright light for 1 h. 
The cells were washed with distilled water before covering with 2.5% sodium thiosulphate (BDH, UK) for 5 
min. Finally, they were counterstained in Neutral Red (N6634, Sigma-Aldrich, UK) for 5 min, washed with 
distilled water, air dried and observed by light microscopy.  
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2.13 Oil Red O staining 
0.5 g of Oil Red O (S267-2, Raymond A. Lamb, London, UK) was mixed with 100 mL of absolute isopropyl 
alcohol (296946H, BDH, UK) and left to stand overnight, while 1 g of dextrin (D2256, Sigma-Aldrich, UK) 
was added to 100 mL of distilled water. By mixing 60 mL of the Oil Red O stock solution with 40 mL of the 
dextrin stock solution an Oil Red O working solution was made and filtered before use with Whatman 540 filter 
paper. Cells were washed with PBS and fixed in formal saline. They were covered with Oil Red O stain for 20 
minutes, rinsed with distilled water to remove excess stain and counter-stained with Harris Haematoxylin for 3 
minutes. Finally, they were rinsed with distilled water, air-dried and observed under light microscopy.  
 
2.14 SEM of cells on discs 
Specimens were fixed in 2.5% glutaraldehyde (Agar Scientific, UK) overnight, washed with 0.1M sodium 
cacodylate buffer (Agar Scientific, UK) and post-fixed in 1% osmium tetroxide (Agar Scientific, UK) in 0.1M 
sodium cacodylate buffer for 1 h. After washing with 0.1M sodium cacodylate buffer, specimens were 
dehydrated through a graded series of industrial methylated spirit (20-60%) and ethanol (70-100%). Finally, 
they were treated for 2×4 minutes with hexamethyldisalazane (Agar Scientific, UK) and left to dry overnight. 
Specimens were mounted on stubs, gold/palladium sputtered coated and observed (JEOL JSM 5500 LV). 
 
2.15 Statistical analysis  
SPSS 14.0 software was used. Multiple comparisons were made using the Kruskal-Wallis test and comparisons 
between groups were made with Mann Whitney U test. A p-value≤0.05 was considered a significant result. 
 
 
3. Results and Discussion 
3.1 Biomimetic soaking method and characterisation of CaP deposits 
Biomimetic soaking methods were originally developed by Kokubo et al. in the 1990s and are based on using 
SBFs that mimic physiological ionic strength and pH [17,18]. When materials are soaked in SBFs a thin apatite-
like layer is obtained over time. Its main advantages are: i) the crystals obtained have been described as bone-
like apatite crystals that are highly bioactive and resorbable; ii) it can be used to evenly coat complex 3D 
structures in contrast to the popular plasma spraying which is a line-of-sight method; iii) the process takes place 
at low temperatures (37 ºC - 50 ºC) and thus heat-sensitive materials such as polymers can be used, unlike other 
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coating methods such as plasma spraying that takes place at high temperatures thus limiting the range of 
materials that can be coated; and iv) since the process is carried out at low temperatures, biological molecules 
(i.e. growth factors) can be incorporated in the coating if desired. However, one disadvantage of the biomimetic 
method is that long immersion times (up to 30 days) in SBF are needed with daily refreshments of the solution 
due to its metastability [17]. Moreover, materials need to be pre-treated to induce precipitation of CaP crystals 
from SBF. In the case of metals, mixed-acid or alkali treatments are applied to roughen the metal surface to 
promote adhesion between CaP crystals and the substrate [19,20]. When working with Ti materials, researchers 
anodise their surface to create a TiO2 layer that makes the surface more bioactive for the biomimetic soaking 
process [20]. Adding a pre-treatment step to the biomimetic soaking process introduces a layer of complexity to 
the procedure. In our study, no pre-treatment of samples was used to induce deposition of CaP deposits thus 
offering an advantage in terms of simplicity and cost-effectiveness.  
 
The biomimetic soaking method used in this study was adapted from Habibovic et al. 2002, who used a rapid 
two step procedure on metal implants. Firstly, samples are soaked in a solution (SBF-1) that is five times more 
concentrated than regular simulated body fluid. In this first step the authors reported that a thin and uniform 
amorphous CaP layer was deposited on the metal surface. Secondly, samples are immersed in the SBF-2 
solution, which has similar composition to that of SBF-1 but with decreased contents of crystal growth 
inhibitors (Mg2+ and HCO3
-). During this second coating step, a fast precipitation of a 30 µm thick crystalline 
CaP coating was observed. The biomimetic coating produced by this two step procedure was found to closely 
resemble bone mineral [21]. Other rapid biomimetic procedures using concentrated SBF solutions can be found 
in the literature [22].  
 
Our aim was to functionalise the metal surfaces with CaP apatite-like deposits rather than creating a uniform 
coating. We hypothesised that crystal growth can be controlled by controlling the immersion time in SBF-2.  
 
3.1.1 Morphology and size of CaP deposits (SEM) 
Our results showed that immersion time in SBF-2 influenced crystal morphology and growth (Fig. 3A). For Ta 
discs, 48 h of immersion in SBF-2 did not produce a uniform coating but rather deposits scattered through the 
surface. These deposits were amorphous nano-sized particles that aggregated to form globular structures in the 
micro-scale with nano-features such as nano-pores and nano-topography (Fig. 3A). An immersion time of 60 h 
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resulted in the formation of an amorphous coating that lacked a structure alongside the nano-sized deposits 
already seen together with plate-like crystals (Fig. 3A). SEM showed that the surface was entirely coated. 
Further immersion in SBF-2 (72 h) produced a uniform coating on the surface of the discs composed of mainly 
plate-like crystals in the micro-scale with a few of the nano-sized particles (Fig. 3A). For TiAl6V4 discs 48 h of 
immersion in SBF-2 resulted in the deposition of a uniform layer of plate-like crystals with some nano-sized 
particles (Fig. 3A). When immersion time in SBF-2 was reduced to 24 h similar results to 48h were seen. By 
further reducing the immersion time to 18 h only amorphous nano-sized particles organised in globular 
structures were observed (Fig. 3A). As in Ta, these globular deposits were found scattered over the surface. 
Surface topography (smooth or rough) was not found to affect particle morphology and growth. SEM analysis 
suggested that an immersion time of 48 h for Ta discs and 18 h for TiAl6V4 discs produced deposits composed 
of amorphous nano-sized particles.  
 
3.1.2 Elemental composition (EDAX) 
For both Ta and TiAl6V4 at the shortest times of immersion in SBF-2 (48 h and 18 h respectively) the deposits 
composed of amorphous nano-sized particles had Ca and P as main elements with Ca/P ratios below 1.67 (that 
of stoichiometric hydroxyapatite), suggesting they were Ca deficient (Fig. 3B). All the spectra contained carbon 
(C) and oxygen (O) peaks. Moreover, the majority of the spectra had a peak for Mg, one of the substituting 
elements found in bone mineral [23-25].  
 
After 60 h and 24 h of immersion in SBF-2 for Ta and TiAl6V4 respectively a different crystal morphology  
developed (plate-like micro-crystals) suggesting the presence of a different mineral phase: EDAX showed that 
Ca and P were still the main elements but the Ca/P ratios were around 2, suggesting another mineral phase not 
as Ca deficient with considerably less P than the amorphous nano-sized particles (Fig. 3B). A Mg peak was still 
present in the majority of the spectra for both surfaces. At the longest times of incubation  (72 h for Ta and 48 h 
for TiAl6V4) no P was detected in the EDAX spectra for coatings on Ta while for TiAl6V4 only one of the 
spectra showed a peak for P with a Ca/P=2.07 (Fig. 3B). This suggested that the other mineral phase present in 
the coatings was constituted primarily of Ca. It also suggested that with increasing immersion time in SBF-2 the 
Ca deficient CaP mineral phase of the nano-sized deposits converted into the Ca-rich mineral phase of the plate-
like micro-crystals. This conversion was complete to a larger extent for Ta after 72 h immersion in SBF-2 than 
for TiAl6V4 after 48 h of immersion in SBF-2.  
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Figure 3. A) Representative SEM images for both Ta and TiAl6V4 showing the different mineral morphologies 
obtained with different immersion time in SBF-2. *shows uncoated metal disc surface. B) Summary of EDAX 
results.  
 
 
 
3.1.3 Phase composition and crystallinity (XRD) 
For the samples containing the CaP deposits composed of amorphous and nano-sized particles no peaks other 
than those corresponding to the metals were observed in the XRD patterns (Fig. 4). Amorphous phases 
composed of very small particles in the nano-metre scale usually give rise to very broad peaks or even an 
amorphous halo on XRD [26,27]. Samples containing both morphologies showed peaks corresponding to calcite 
(CaCO3), a Ca mineral found in biological systems [28]. The peaks appeared large due to the very high 
symmetry for calcite. 
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Figure 4. XRD results for both metals. Red arrows point at Ta peaks. Blue arrows point at TiAl6V4 peaks. 
Green arrows point at peaks for calcite (CaCO3). 
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3.1.4 Micro-Raman spectroscopy 
Smooth samples (both Ta and TiAl6V4) containing both morphologies showed bands at 154, 282, 711 and 1088 
cm-1 corresponding to the calcite phase [29]. Both hydroxyapatite and β-tricalcium phosphate have phosphate 
groups that give an intense Raman band around 960 cm-1 (P-O symmetric stretch), so the absence of any band in 
that region indicated that no crystalline phosphate phases had been formed during the treatment.  
 
All together, this data suggests that the biomimetic deposits are composed of an amorphous CaP phase, 
composed of nano-sized particles, which are Ca deficient. Mg, one of the reported substituting ions found in 
bone mineral [23-25], may be incorporated in the deposits. The presence of a C peak in the EDAX spectra could 
suggest the presence of a carbonate group in the deposits. However, it could also be due to general 
contamination as C is ubiquitous. 
 
We concluded that 48 h and 18 h immersion time in SBF-2 for Ta and TiAl64 respectively were optimum. The 
difference in immersion time between both metals could be due to the excellent biocompatibility shown by 
titanium materials. The biocompatibility of these materials is based on a thin dioxide (TiO2, in the case of 
titanium) layer formed on the surface of the bulk material. Ti is a very reactive element even at room 
temperature and a newly polished titanium surface will almost immediately have a thin layer of TiO2 [1].  
 
3.1.5 Thickness of CaP deposits 
The maximum thickness of the CaP deposits after 48 h and 18 h immersion time in SBF-2 for Ta and TiAl64 
respectively was determined by SEM (Fig. 5). Micrographs confirmed that the discs’ surface was not completely 
covered by a mineral layer. The globular nature of the CaP deposits was also observed. Maximum thickness of 
the CaP deposits was slightly higher for TiAl6V4 than for Ta discs (Fig. 5). 
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Figure 5. Thickness of CaP deposits (SEM). A-D) Cross-sections of discs showing the globular CaP deposits 
scattered through the surfaces. E) Maximum thickness of CaP deposits as measured by SEM. 
 
 
3.1.6 Apatite layer formation 
As it has been shown that CaP materials promote direct bonding with bone tissue through formation of an 
apatite layer, in vitro models for studying apatite formation on the surface of different biomaterials are used as 
an assessment of their bioactivity and osteoconductivity. These in vitro models use the method developed by 
Kokubo and co-workers in the 1990s [17,18,30] where biomaterials are immersed in SBF and the mineral layer 
formed on their surface is subsequently characterised. Since surface topography and metal type did not affect 
the morphology and composition of CaP coatings deposited on TiAl6V4 and Ta discs, only TiAl6V4 discs with 
a smooth surface were used for this study. TiAl6V4 discs without CaP deposits were used as controls.  
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SEM analysis revealed mineral deposits at day 1 on control discs, which became denser after 7 days (Fig. 6A). 
Close observation of these deposits at day 1 showed that they were composed of 2 to 3µm diameter globular 
crystals that tended to aggregate in larger globular structures (Fig. 6A). These morphologies resemble the 
apatitic globular crystals described by Kokubo and co-workers on the surfaces of ceramics, metals and polymers 
when immersed in SBF [18,30]. Interestingly, at day 7 mineral deposits of nano-sized particles very similar to 
those observed after our biomimetic method, were seen (Fig. 6A, red arrows). Biomimetic CaP deposits became 
denser after immersion in SBF for 1 day and almost completely covered the disc surface (Fig. 6B). After 7 days, 
globular amorphous crystals in the micro-meter scale, were observed in some areas (Fig. 6B). Ca and P peaks 
were barely detected by EDAX analysis on the control discs at day 1 however, they were clearly visible at day 
7, including a peak for Mg (Fig. 6A). For the discs with CaP deposits, apart from Ca, P, C and O peaks, Na, Cl 
and Mg peaks were also visible in the spectra. Calculated Ca/P ratios were similar to those observed at day 0 
(Fig. 6B), showing that all the CaP deposits were Ca deficient.  
 
These results suggest that the CaP deposits obtained following our biomimetic method would act as a catalyst to 
rapidly form a Ca deficient CaP layer that also incorporates Mg when incubated with SBF, thus demonstrating 
their bioactivity. Mg is one of the substituting ions in bone mineral [23] and recent research incorporating Mg 
into CaP materials and coatings have shown that it increases proliferation and osteogenic differentiation of both 
osteoprogenitor and osteoblast-like cells [31,32], as well as facilitating bone healing by providing 
immunomodulation and influencing crosstalk between macrophages and osteogenesis-related cells [32]. 
Furthermore, results also suggest that our biomimetic coating method accelerates the deposition mechanism of 
apatite crystals on metal surfaces normally observed after immersion in regular SBF: globular apatitic structures 
of 2-3 µm diameter are first deposited that later aggregate in larger globular structures, which then evolve into 
structures composed of CaP nano-sized crystals that incorporate available ions in the environment (i.e. Mg2+). 
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Figure 6. Apatite layer formation results. A) Smooth TiAl6V4 discs without CaP deposits (Control) and B) 
smooth TiAl6V4 discs with CaP deposits. Red arrows in SEM images point at mineral deposits of nano-sized 
particles. Red arrows in EDAX spectra point at Ca (main peak) and P peaks, blue arrows point at Mg peaks 
while green arrows point at Na and Cl peaks. 
 
 
 
3.2 In vitro cell work 
A clinically relevant source of cells was used to study biocompatibility and osteogenic potential of the CaP 
deposits. Following a bone injury, mesenchymal stem cells (MSCs) are recruited into the injury site and 
differentiate into bone cells due to environmental cues [34]. Moreover, MSCs secrete trophic agents and pro-
angiogenic factors that recruit resident MSCs to the injury site and promote angiogenesis, which is critical for 
tissue regeneration [34].  
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3.2.1 Characterisation of BM-MSCs 
Since the BM-MSCs used in this study were primary cells it was important to characterise them before seeding 
them on the materials. BM-MSCs were first described by Friedestein and co-workers in the 1970s, who 
observed that these cells adhered to tissue culture plates and resembled fibroblasts in vitro [35,36]. As BM-
MSCs have the potential to differentiate into lineages of mesenchymal tissues, these cells are often 
characterised by demonstrating their multipotency differentiating them down two or more mesenchymal 
lineages [37-39], such as the adipogenic and osteogenic lineages. After 21 days of culture under adipogenic 
conditions, Oil Red O staining showed the presence of lipids as well as a clear difference in morphology (Fig. 
7A) [37,38]. Changes in morphology were also observed in MSCs cultured under osteogenic conditions with 
cells becoming polygonal (Fig. 7B): an osteoblast feature [40]. Mineral deposits, representative of mineralised 
matrix formation, were stained with Von Kossa in the osteogenic samples after 28 days (Fig. 7B) [38]. DNA 
concentration (Fig. 7B) of BM-MSCs in osteogenic medium was higher at all time points than that of the 
control samples indicating that the osteogenic supplements added to the culture medium stimulated cell 
proliferation as well as differentiation [41,42]. ALP/DNA of osteogenic cultures was also higher at all time 
points, similar to that described in the literature (Fig. 7B) [41,43]: ALP activity elevates when BM-MSCs begin 
to differentiate and peaks between days 8 and 12 (day 14 in this study), which coincides with their commitment 
to become osteoblasts. Thus, ALP expression is an early marker of osteogenic differentiation. Together these 
results demonstrated the multipotency of the cells used in this study. 
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Figure 7. Characterisation of BM-MSCs. A) Adipogenic differentiation: Oil Red O staining at day 21 where red 
spots indicate presence of lipids. B) Osteogenic differentiation: DNA concentration and ALP/DNA activity 
(*p≤0.05), Von Kossa staining at ay 28 where black deposits indicate mineral deposition, SEM showing 
spindle-shaped cells in standard cultures and polygonal cells in osteogenic cultures. 
 
 
3.2.2 Culture of BM-MSCs on metal discs 
Since early implant fixation is the key to reduce the incidence of implant loosening [44,45], we investigated 
early (up to 14 days) BM-MSCs attachment, proliferation and osteogenic differentiation as an indication of 
initial cell response to the CaP deposits. Metal discs without CaP deposits were used as controls. No osteogenic 
supplements were used. Results showed that the CaP deposits increased initial attachment and proliferation of 
BM-MSCs (Fig. 8A,B). On the control discs cells proliferated more on smooth surfaces than on rough ones 
(Fig. 8A,B), as previously reported in an earlier study and in the literature [9,46]. This trend was also observed 
on the discs with CaP deposits although only at the early time points (days 4 and 7). In terms of early osteogenic 
differentiation, results showed that the CaP deposits induced osteogenic differentiation of BM-MSCs as 
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measured by ALP activity and was significantly higher on these surfaces compared to the controls (Fig. 8C). 
CaP materials and coatings have been shown to induce differentiation of MSCs down the osteogenic lineage 
[9,47,48] and we mentioned before that incorporating Mg into CaP materials has been shown to have a positive 
effect on proliferation and osteogenic differentiation of different cell types [31,32]. Therefore, our findings are 
consistent with previous reports and support the inclusion of Mg in CaP coatings for enhanced osteogenic 
differentiation of BM-MSCs. Furthermore, on the discs with CaP deposits, ALP activity was significantly 
higher on the rough surfaces than on the smooth ones on both days 7 and 14 (Fig. 8C). Finally, the type of metal 
(Ta or TiAl6V4) did not have a significant effect on early cell attachment, proliferation and differentiation. 
 
SEM of control discs showed that on smooth surfaces cells were orientated to one another in a parallel way and 
displayed a flattened morphology. After 7 days in culture, cells were in contact with each other and displayed 
multiple cytoplasmic processes for cell attachment (Fig. 8D). On the other hand, patches of cells were observed 
covering the surface of rough discs (Fig. 8D). They were also in contact with each other and displayed long 
cytoplasmic processes. On the discs with CaP deposits, SEM at day 4 clearly showed that BM-MSCs use the 
CaP deposits to attach to the discs’ surfaces. By day 7 a dense cell layer was seen covering the surface of the 
discs in some areas. By day 14 it was difficult of see individual cells as the discs’ surfaces were almost 
confluent. Up to day 14 a mix of cellular shapes could be seen with two main morphologies distinguished: long, 
spindle cells and squarer, polygonal cells (Fig. 8D).  
 
Together, these results suggest that the biomimetic, amorphous CaP apatite-like deposits promote initial 
attachment, proliferation and osteogenic differentiation of BM-MSCs. 
 
Page 21 of 29 AUTHOR SUBMITTED MANUSCRIPT - BMM-101814.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
 M
a
us
cri
pt
22 
 
 
Figure 8. Culture of BM-MSCs on the metal discs for 14 days: A) alamarBlue activity assay; B) DNA 
concentration; C) ALP/DNA activity; D) SEM of control discs; and E) SEM of discs with CaP deposits. 
 
 
3.3 3D porous structures 
The last stage in our study was to use our method with selective laser sintered 3D porous metal structures, which 
are generating considerable interest due to their greater tissue ingrowth potential [1,45,49]. A highly porous 
structure that presents open and interconnected pores is advantageous: osteoblasts and MSCs migration and 
proliferation in the inner surfaces is necessary to form bone within the porous structures. A number of implants 
are now being made with porous surfaces. As plasma spraying hydroxyapatite is a line-of-site method, only the 
outer pores would be coated, so alternative methods for coating the inner porous surfaces are required such as 
solutions depositing CaP as outlined in this paper. In order for bone to penetrate deep into the porous structures 
vascularisation within the scaffold is necessary [50]. Moreover, 3D porous metal structures allow mechanical 
interlocking between the implant and host bone resulting in a greater stability of the implant. By controlling the 
porosity of the structure, a mismatch in elastic modulus between the implant and the host bone can be reduced, 
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thus minimising implant failure due to stress shielding [51]. In this study we used 3D porous TiAl6V4 structures 
and immersed them into in SBF-2 for 18 h as described previously for TiAl6V4 discs. Results showed that our 
method was able to deposit the amorphous nano-sized CaP particles already seen and described for TiAl6V4 
discs throughout the 3D metal structure (Fig. 9).  
 
 
 
 
Figure 9. A) SEM comparison of 3D porous TiAl6V4 with and without CaP deposits. B) Representative SEM 
image of the amorphous nano-sized CaP particles deposited throughout the 3D porous TiAl6V4 structures. C) 
Cross-section of 3D porous TiAl6V4 showing CaP deposits inside the structure (SEM). D) Maximum thickness 
of CaP deposits as measured by SEM and summary of EDAX results.  
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4. Conclusions 
We hypothesised that the surface of clinically relevant metals (Ta and TiAl6V4) used in dental and orthopaedic 
implants can be functionalised with biomimetic, amorphous CaP apatite-like deposits. Our aims were to 
functionalise the metal surfaces with CaP deposits instead of creating uniform coatings, and to obtain CaP 
deposits composed of nano-particles. Amorphous CaP particles were deposited on different surfaces by a 
biomimetic rapid two-step soaking method using concentrated SBF solutions without pre-treatment of the metal 
surfaces to induce CaP deposition. The CaP deposits were composed of amorphous globular nano-sized particles 
that also contained Mg, C and O. Immersion in regular SBF showed that the CaP deposits obtained following 
our biomimetic method would act as a catalyst to rapidly form a Ca deficient CaP layer that also incorporates 
Mg demonstrating their bioactivity. In vitro cell work showed that the amorphous CaP apatite-like deposits 
promote initial attachment, proliferation and osteogenic differentiation of BM-MSCs. Finally, our method could 
be applied to 3D  structures in order to functionalise the inner  porous surfaces . 
 
The novelty of our work is the approach to functionalize metal surfaces with biomimetic CaP deposits 
(composed of nano-particles and include Mg) that would rapidly form a Ca deficient CaP layer that incorporates 
Mg upon implantation in vivo. Our data also shows that these CaP deposits would promote initial attachment, 
proliferation and osteogenic differentiation of BM-MSCs. So far, functionalization approaches focus on 
modifying metal surface topography or on producing thick CaP coatings. Our study is the first report that 
describes functionalisation of metal implants with bioactive, osteogenic and chemically versatile biomimetic 
CaP deposits. We believe that our approach has great potential for clinical translation and, due to the simplicity 
and cost-effectiveness of our method, it could be easily applicable in the coating prostheses industry. 
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